Search
for
Sort by
Research 241–270 of 524
- Alopecia areata: medical treatments
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Alopecia areata
- Alopecia Areata: Current Review
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- A novel hairless highly immunodeficient mice model optimized for in vivo imaging
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Effect of tofacitinib on the expression of noggin/BMP-4 and hair growth stimulation in mice
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- 1323 The effects of 3-OH of kaempferol on interfollicular epidermal stem cell fate
- 1324 Impairment of hair-inducing capacity of 3D-cultured human dermal papilla cells by the ablation of STAT5
- 1327 Effect of ginsenoside Rd on dermal epidermal junction in fibroblast
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- Alopecia areata
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis